Graphite Stock News

Zacks Investment Research upgraded shares of Graphite Bio (NASDAQ:GRPH) from a sell rating to a hold rating in a research report sent to investors on Tuesday, Zacks.com reports. According to Zacks, Graphite Bio Inc. is a clinical-stage, next-generation gene editing company focused on therapies to treat or cure serious diseases. Graphite Bio Inc. is based []

Graphite Bio: An Important Stock To Track In The Gene Editing Space

Graphite Bio, Inc. (NASDAQ:GRPH)s stock price reached a new 52-week low during mid-day trading on Monday . The company traded as low as $11.61 and last traded at $11.71, with a volume of 679 shares trading hands. The stock had previously closed at $12.17. A number of research analysts have issued reports on the stock. []

Organovo (NASDAQ:ONVO) and Graphite Bio (NASDAQ:GRPH) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings. Profitability This table compares Organovo and Graphite Bios net margins, return on equity and return on []

FMR LLC, the Boston-based asset management company commonly known as Fidelity, disclosed this month that its top-five trades during September included new buys in Toast Inc. ( TOST , Financial), Graph

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $GRPH #GraphiteBio--Graphite Bio, Inc. (Nasdaq: GRPH), a clinical-stage, next-generation gene editing company focused on therapies that harness targete

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $GRPH #GraphiteBio--Graphite Bio, Inc. (Nasdaq: GRPH), a clinical-stage, next-generation gene editing company harnessing high-efficiency precision gene

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $GRPH #GraphiteBio--Graphite Bio, Inc. (Nasdaq: GRPH), a clinical-stage, next-generation gene editing company focused on therapies that harness targete

Graphite Bio Inc (NASDAQ: GRPH) is set to go public on the heels of a $238 million raise less than ten months after getting started with a Series A funding of $45 million.  Graphite is using a fa

Acurx Pharmaceuticals, Alpha Teknova, Elevation Oncology, GH Research, Graphite Bio, and MissFresh are listed on the Nasdaq. Mister Car Wash is trading the New York Stock Exchange.

Graphite Bio Inc. received a warm reception on Wall Street, as the California-based gene-editing biotechnology company's stock opened 30% above its initial public offering price. The IPO priced overni

Shares of Graphite Bio Inc. are set to start trading Friday, after the California-based gene-editing biotechnology company's upsized initial public offering priced at the top of the expected range. Th

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Graphite Bio, Inc., a clinical-stage, next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure se